Showing 181 - 200 results of 145,726 for search '(( 10 ((teer decrease) OR (a decrease)) ) OR ( 5 ((mg decrease) OR (nn decrease)) ))', query time: 0.73s Refine Results
  1. 181
  2. 182
  3. 183
  4. 184
  5. 185
  6. 186

    Fig 5 - by Hanna Rauch (12191278)

    Published 2022
    Subjects:
  7. 187

    MG-suppressed cell proliferation in a xenotransplantation model. by Chien-Yu Huang (802982)

    Published 2021
    “…Fluorescence labeled Hep3B and HepJ5 cells were implanted into an embryo yolk of the zebrafish, and then embryos were exposed to 40 μg/ml MG or dH<sub>2</sub>O as a vehicle control. …”
  8. 188

    Vitamin D3, but not the Cisplatin, could moderately reduce STZ-induced hyperglycemia in mice (a) Schematic representation of experimental protocol followed in the study: After accl... by Vidya G. Bettada (22208808)

    Published 2025
    “…Interestingly the FBG is increased in the mice treated with cisplatin (2.5mg/Kg) in the final two time points.</p> <p>(TIF)</p>…”
  9. 189
  10. 190
  11. 191
  12. 192

    Fig 4 - by Sinthia Kabir Mumu (17705902)

    Published 2023
    Subjects:
  13. 193

    S1 Data - by Sinthia Kabir Mumu (17705902)

    Published 2023
    Subjects:
  14. 194

    S2 Data - by Sinthia Kabir Mumu (17705902)

    Published 2023
    Subjects:
  15. 195
  16. 196
  17. 197
  18. 198

    Global Land Use Change Impacts on Soil Nitrogen Availability and Environmental Losses by Jing Wang (6206297)

    Published 2025
    “…By compiling a global data set of 1,782 paired observations from 185 publications, we show that land use conversion from natural to managed ecosystems significantly reduced NNM by 7.5% (−11.5, −2.8%) and increased NN by 150% (86, 194%), indicating decreasing N availability while increasing potential N loss through denitrification and nitrate leaching. …”
  19. 199
  20. 200

    Supplementary Material for: SGLT2 inhibitors decrease overhydration and proteasuria in patients with chronic kidney disease: a longitudinal observational study by Schork A. (17795387)

    Published 2024
    “…Results: 42 patients (29 % with diabetic/hypertensive CKD, 31 % with IgA nephropathy; 88 % dapagliflozin 10 mg, 10 % dapagliflozin 5 mg, 2 % empagliflozin 20 mg; median eGFR 46 mL/min/1.73m² and albuminuria 1911 mg/g creatinine) participated in the study. …”